ASTH vs MD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
ASTH
MD
Investment Advisor Scores
MD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ASTH | MD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.009 | 9.2937 | ASTH |
| PEG Ratio | 0 | 0.2433 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.1% | 1.7% | ASTH |
| Earnings Growth | 3331.0% | -29.8% | ASTH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 41.5/100 | 32.1/100 | ASTH |
| Profit Margin | 1.4% | 7.7% | MD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | ASTH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ASTH
MarkdownPrice below a falling SMA50 (slope -0.8%), weak momentum, RSI 34
MD
MarkupPrice above SMA50, rising 50-day trend (4.7% over 20 days), RSI 68
Fundamentals Snapshot
| Metric | ASTH | MD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.9 | 12.8 |
| Trailing P/E | 31.9 | 17.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.1% | 0.3% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 1.06 | 1.83 |
| Dividend Yield | — | — |